The NIH Postdoc Experience

Mention the National Institutes of Health to any science graduate student and the name conjures up images of top-notch researchers in white lab coats, doing cutting-edge science with lots of money to spend but very little space. Moreover, the NIH always seemed to me to be "Science Central" for the United States, because NIH grants support research nationwide, and because every prominent faculty member of my graduate school program ran off to attend study sections. The rhetorical question that s

Written byRamie Leibnitz
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Mention the National Institutes of Health to any science graduate student and the name conjures up images of top-notch researchers in white lab coats, doing cutting-edge science with lots of money to spend but very little space. Moreover, the NIH always seemed to me to be "Science Central" for the United States, because NIH grants support research nationwide, and because every prominent faculty member of my graduate school program ran off to attend study sections. The rhetorical question that shone in my starry eyes was: What newly graduated Ph.D. would not like to have a postdoctoral experience at the NIH?

As I got closer to my own elusive Ph.D. degree and probed more deeply into future options, I heard some other reports. "The NIH is a postdoc mill"; "it's dark, messy, and crowded"; the postdocs work 18-hour days"; "the principal investigators have personality disorders, probably due to enlargement of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies